Refresh

Parenteral Drugs (India) Ltd. - Research Center

524689 PARENTLD Group (Z) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Income

Operating income

8.50 12.17 31.87 32.03 32.95
Expenses

Material consumed

5.47 5.67 6.78 7.17 6.95

Manufacturing expenses

- 1.64 15.90 17.27 14.41

Personnel expenses

14.79 14.51 19.21 19.94 16.70

Selling expenses

- - 0.03 0.04 0.13

Adminstrative expenses

3.26 2.11 4.63 5.27 10.60

Expenses capitalised

- - - - -

Cost of sales

23.51 23.94 46.56 49.68 48.79

Operating profit

-15.01 -11.77 -14.68 -17.66 -15.84

Other recurring income

0.07 0.06 0.25 1.44 1.34

Adjusted PBDIT

-14.94 -11.71 -14.43 -16.22 -14.50

Financial expenses

106.25 125.44 109.96 96.05 86.34

Depreciation

40.15 17.33 17.35 69.12 18.57

Other write offs

- - - - -

Adjusted PBT

-161.34 -154.47 -141.73 -181.39 -119.40

Tax charges

-32.76 -32.76 -27.66 -33.49 -23.31

Adjusted PAT

-128.57 -121.71 -114.07 -147.90 -96.09

Non recurring items

52.21 0.14 -0.31 -0.25 -0.02

Other non cash adjustments

- - - - -

Reported net profit

-76.36 -121.57 -114.38 -148.16 -96.12

Earnigs before appropriation

-76.36 -1,034.97 -913.41 -799.02 -650.87

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-76.36 -1,034.97 -913.41 -799.02 -650.87
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com